Animal-derived Immune Globulin Industry Research Report 2025
Description
Summary
According to APO Research, the global Animal-derived Immune Globulin market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Animal-derived Immune Globulin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Animal-derived Immune Globulin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Animal-derived Immune Globulin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Animal-derived Immune Globulin include Sanofi, Merck, Pfizer, Wyeth Pharmaceuticals, Rare Disease Therapeutics, Protherics and Genzyme, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal-derived Immune Globulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal-derived Immune Globulin.
The report will help the Animal-derived Immune Globulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Animal-derived Immune Globulin market size, estimations, and forecasts are provided in terms of sales volume (k tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal-derived Immune Globulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Animal-derived Immune Globulin Segment by Company
Sanofi Merck Pfizer Wyeth Pharmaceuticals Rare Disease Therapeutics Protherics GenzymeAnimal-derived Immune Globulin Segment by Type
Liquid PowderAnimal-derived Immune Globulin Segment by Application
Hospital ClinicAnimal-derived Immune Globulin Segment by Region
North America United States Canada Europe Germany France U.K. Italy Netherlands Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal-derived Immune Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal-derived Immune Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal-derived Immune Globulin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Animal-derived Immune Globulin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Animal-derived Immune Globulin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Animal-derived Immune Globulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Animal-derived Immune Globulin market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Animal-derived Immune Globulin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Animal-derived Immune Globulin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Animal-derived Immune Globulin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Animal-derived Immune Globulin include Sanofi, Merck, Pfizer, Wyeth Pharmaceuticals, Rare Disease Therapeutics, Protherics and Genzyme, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal-derived Immune Globulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal-derived Immune Globulin.
The report will help the Animal-derived Immune Globulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Animal-derived Immune Globulin market size, estimations, and forecasts are provided in terms of sales volume (k tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal-derived Immune Globulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Animal-derived Immune Globulin Segment by Company
Sanofi Merck Pfizer Wyeth Pharmaceuticals Rare Disease Therapeutics Protherics GenzymeAnimal-derived Immune Globulin Segment by Type
Liquid PowderAnimal-derived Immune Globulin Segment by Application
Hospital ClinicAnimal-derived Immune Globulin Segment by Region
North America United States Canada Europe Germany France U.K. Italy Netherlands Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal-derived Immune Globulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal-derived Immune Globulin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal-derived Immune Globulin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Animal-derived Immune Globulin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Animal-derived Immune Globulin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Animal-derived Immune Globulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
118 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Animal-derived Immune Globulin Market Size (2020-2031)
- 2.2.2 Global Animal-derived Immune Globulin Sales (2020-2031)
- 2.2.3 Global Animal-derived Immune Globulin Market Average Price (2020-2031)
- 2.3 Animal-derived Immune Globulin by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Liquid
- 2.3.3 Powder
- 2.4 Animal-derived Immune Globulin by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Animal-derived Immune Globulin Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Animal-derived Immune Globulin Sales (k tons) of Manufacturers (2020-2025)
- 3.3 Global Animal-derived Immune Globulin Revenue of Manufacturers (2020-2025)
- 3.4 Global Animal-derived Immune Globulin Average Price by Manufacturers (2020-2025)
- 3.5 Global Animal-derived Immune Globulin Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Animal-derived Immune Globulin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Animal-derived Immune Globulin, Product Type & Application
- 3.8 Global Manufacturers of Animal-derived Immune Globulin, Established Date
- 3.9 Global Animal-derived Immune Globulin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Sanofi Animal-derived Immune Globulin Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Merck Animal-derived Immune Globulin Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Pfizer Animal-derived Immune Globulin Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Wyeth Pharmaceuticals
- 4.4.1 Wyeth Pharmaceuticals Company Information
- 4.4.2 Wyeth Pharmaceuticals Business Overview
- 4.4.3 Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolio
- 4.4.5 Wyeth Pharmaceuticals Recent Developments
- 4.5 Rare Disease Therapeutics
- 4.5.1 Rare Disease Therapeutics Company Information
- 4.5.2 Rare Disease Therapeutics Business Overview
- 4.5.3 Rare Disease Therapeutics Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolio
- 4.5.5 Rare Disease Therapeutics Recent Developments
- 4.6 Protherics
- 4.6.1 Protherics Company Information
- 4.6.2 Protherics Business Overview
- 4.6.3 Protherics Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Protherics Animal-derived Immune Globulin Product Portfolio
- 4.6.5 Protherics Recent Developments
- 4.7 Genzyme
- 4.7.1 Genzyme Company Information
- 4.7.2 Genzyme Business Overview
- 4.7.3 Genzyme Animal-derived Immune Globulin Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Genzyme Animal-derived Immune Globulin Product Portfolio
- 4.7.5 Genzyme Recent Developments
- 5 Global Animal-derived Immune Globulin Market Scenario by Region
- 5.1 Global Animal-derived Immune Globulin Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Animal-derived Immune Globulin Sales by Region: 2020-2031
- 5.2.1 Global Animal-derived Immune Globulin Sales by Region: 2020-2025
- 5.2.2 Global Animal-derived Immune Globulin Sales by Region: 2026-2031
- 5.3 Global Animal-derived Immune Globulin Revenue by Region: 2020-2031
- 5.3.1 Global Animal-derived Immune Globulin Revenue by Region: 2020-2025
- 5.3.2 Global Animal-derived Immune Globulin Revenue by Region: 2026-2031
- 5.4 North America Animal-derived Immune Globulin Market Facts & Figures by Country
- 5.4.1 North America Animal-derived Immune Globulin Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Animal-derived Immune Globulin Sales by Country (2020-2031)
- 5.4.3 North America Animal-derived Immune Globulin Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Animal-derived Immune Globulin Market Facts & Figures by Country
- 5.5.1 Europe Animal-derived Immune Globulin Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Animal-derived Immune Globulin Sales by Country (2020-2031)
- 5.5.3 Europe Animal-derived Immune Globulin Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Animal-derived Immune Globulin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Animal-derived Immune Globulin Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Animal-derived Immune Globulin Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Animal-derived Immune Globulin Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Animal-derived Immune Globulin Market Facts & Figures by Country
- 5.7.1 South America Animal-derived Immune Globulin Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Animal-derived Immune Globulin Sales by Country (2020-2031)
- 5.7.3 South America Animal-derived Immune Globulin Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Animal-derived Immune Globulin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Animal-derived Immune Globulin Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Animal-derived Immune Globulin Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Animal-derived Immune Globulin Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Animal-derived Immune Globulin Sales by Type (2020-2031)
- 6.1.1 Global Animal-derived Immune Globulin Sales by Type (2020-2031) & (k tons)
- 6.1.2 Global Animal-derived Immune Globulin Sales Market Share by Type (2020-2031)
- 6.2 Global Animal-derived Immune Globulin Revenue by Type (2020-2031)
- 6.2.1 Global Animal-derived Immune Globulin Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Animal-derived Immune Globulin Revenue Market Share by Type (2020-2031)
- 6.3 Global Animal-derived Immune Globulin Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Animal-derived Immune Globulin Sales by Application (2020-2031)
- 7.1.1 Global Animal-derived Immune Globulin Sales by Application (2020-2031) & (k tons)
- 7.1.2 Global Animal-derived Immune Globulin Sales Market Share by Application (2020-2031)
- 7.2 Global Animal-derived Immune Globulin Revenue by Application (2020-2031)
- 7.2.1 Global Animal-derived Immune Globulin Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Animal-derived Immune Globulin Revenue Market Share by Application (2020-2031)
- 7.3 Global Animal-derived Immune Globulin Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Animal-derived Immune Globulin Value Chain Analysis
- 8.1.1 Animal-derived Immune Globulin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Animal-derived Immune Globulin Production Mode & Process
- 8.2 Animal-derived Immune Globulin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Animal-derived Immune Globulin Distributors
- 8.2.3 Animal-derived Immune Globulin Customers
- 9 Global Animal-derived Immune Globulin Analyzing Market Dynamics
- 9.1 Animal-derived Immune Globulin Industry Trends
- 9.2 Animal-derived Immune Globulin Industry Drivers
- 9.3 Animal-derived Immune Globulin Industry Opportunities and Challenges
- 9.4 Animal-derived Immune Globulin Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Animal-derived Immune Globulin Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Animal-derived Immune Globulin Sales (k tons) of Manufacturers (2020-2025)
- Table 7. Global Animal-derived Immune Globulin Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Animal-derived Immune Globulin Revenue of Manufacturers (2020-2025)
- Table 9. Global Animal-derived Immune Globulin Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Animal-derived Immune Globulin Average Price (US$/ton) of Manufacturers (2020-2025)
- Table 11. Global Animal-derived Immune Globulin Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Animal-derived Immune Globulin, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Animal-derived Immune Globulin, Product Type & Application
- Table 14. Global Animal-derived Immune Globulin Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Animal-derived Immune Globulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Sanofi Company Information
- Table 19. Sanofi Business Overview
- Table 20. Sanofi Animal-derived Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 21. Sanofi Animal-derived Immune Globulin Product Portfolio
- Table 22. Sanofi Recent Developments
- Table 23. Merck Company Information
- Table 24. Merck Business Overview
- Table 25. Merck Animal-derived Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 26. Merck Animal-derived Immune Globulin Product Portfolio
- Table 27. Merck Recent Developments
- Table 28. Pfizer Company Information
- Table 29. Pfizer Business Overview
- Table 30. Pfizer Animal-derived Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 31. Pfizer Animal-derived Immune Globulin Product Portfolio
- Table 32. Pfizer Recent Developments
- Table 33. Wyeth Pharmaceuticals Company Information
- Table 34. Wyeth Pharmaceuticals Business Overview
- Table 35. Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 36. Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolio
- Table 37. Wyeth Pharmaceuticals Recent Developments
- Table 38. Rare Disease Therapeutics Company Information
- Table 39. Rare Disease Therapeutics Business Overview
- Table 40. Rare Disease Therapeutics Animal-derived Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 41. Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolio
- Table 42. Rare Disease Therapeutics Recent Developments
- Table 43. Protherics Company Information
- Table 44. Protherics Business Overview
- Table 45. Protherics Animal-derived Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 46. Protherics Animal-derived Immune Globulin Product Portfolio
- Table 47. Protherics Recent Developments
- Table 48. Genzyme Company Information
- Table 49. Genzyme Business Overview
- Table 50. Genzyme Animal-derived Immune Globulin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2020-2025)
- Table 51. Genzyme Animal-derived Immune Globulin Product Portfolio
- Table 52. Genzyme Recent Developments
- Table 53. Global Animal-derived Immune Globulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 54. Global Animal-derived Immune Globulin Sales by Region (2020-2025) & (k tons)
- Table 55. Global Animal-derived Immune Globulin Sales Market Share by Region (2020-2025)
- Table 56. Global Animal-derived Immune Globulin Sales by Region (2026-2031) & (k tons)
- Table 57. Global Animal-derived Immune Globulin Sales Market Share by Region (2026-2031)
- Table 58. Global Animal-derived Immune Globulin Revenue by Region (2020-2025) & (US$ Million)
- Table 59. Global Animal-derived Immune Globulin Revenue Market Share by Region (2020-2025)
- Table 60. Global Animal-derived Immune Globulin Revenue by Region (2026-2031) & (US$ Million)
- Table 61. Global Animal-derived Immune Globulin Revenue Market Share by Region (2026-2031)
- Table 62. North America Animal-derived Immune Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 63. North America Animal-derived Immune Globulin Sales by Country (2020-2025) & (k tons)
- Table 64. North America Animal-derived Immune Globulin Sales by Country (2026-2031) & (k tons)
- Table 65. North America Animal-derived Immune Globulin Revenue by Country (2020-2025) & (US$ Million)
- Table 66. North America Animal-derived Immune Globulin Revenue by Country (2026-2031) & (US$ Million)
- Table 67. Europe Animal-derived Immune Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 68. Europe Animal-derived Immune Globulin Sales by Country (2020-2025) & (k tons)
- Table 69. Europe Animal-derived Immune Globulin Sales by Country (2026-2031) & (k tons)
- Table 70. Europe Animal-derived Immune Globulin Revenue by Country (2020-2025) & (US$ Million)
- Table 71. Europe Animal-derived Immune Globulin Revenue by Country (2026-2031) & (US$ Million)
- Table 72. Asia Pacific Animal-derived Immune Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 73. Asia Pacific Animal-derived Immune Globulin Sales by Country (2020-2025) & (k tons)
- Table 74. Asia Pacific Animal-derived Immune Globulin Sales by Country (2026-2031) & (k tons)
- Table 75. Asia Pacific Animal-derived Immune Globulin Revenue by Country (2020-2025) & (US$ Million)
- Table 76. Asia Pacific Animal-derived Immune Globulin Revenue by Country (2026-2031) & (US$ Million)
- Table 77. South America Animal-derived Immune Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 78. South America Animal-derived Immune Globulin Sales by Country (2020-2025) & (k tons)
- Table 79. South America Animal-derived Immune Globulin Sales by Country (2026-2031) & (k tons)
- Table 80. South America Animal-derived Immune Globulin Revenue by Country (2020-2025) & (US$ Million)
- Table 81. South America Animal-derived Immune Globulin Revenue by Country (2026-2031) & (US$ Million)
- Table 82. Middle East and Africa Animal-derived Immune Globulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 83. Middle East and Africa Animal-derived Immune Globulin Sales by Country (2020-2025) & (k tons)
- Table 84. Middle East and Africa Animal-derived Immune Globulin Sales by Country (2026-2031) & (k tons)
- Table 85. Middle East and Africa Animal-derived Immune Globulin Revenue by Country (2020-2025) & (US$ Million)
- Table 86. Middle East and Africa Animal-derived Immune Globulin Revenue by Country (2026-2031) & (US$ Million)
- Table 87. Global Animal-derived Immune Globulin Sales by Type (2020-2025) & (k tons)
- Table 88. Global Animal-derived Immune Globulin Sales by Type (2026-2031) & (k tons)
- Table 89. Global Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
- Table 90. Global Animal-derived Immune Globulin Sales Market Share by Type (2026-2031)
- Table 91. Global Animal-derived Immune Globulin Revenue by Type (2020-2025) & (US$ Million)
- Table 92. Global Animal-derived Immune Globulin Revenue by Type (2026-2031) & (US$ Million)
- Table 93. Global Animal-derived Immune Globulin Revenue Market Share by Type (2020-2025)
- Table 94. Global Animal-derived Immune Globulin Revenue Market Share by Type (2026-2031)
- Table 95. Global Animal-derived Immune Globulin Price by Type (2020-2025) & (US$/ton)
- Table 96. Global Animal-derived Immune Globulin Price by Type (2026-2031) & (US$/ton)
- Table 97. Global Animal-derived Immune Globulin Sales by Application (2020-2025) & (k tons)
- Table 98. Global Animal-derived Immune Globulin Sales by Application (2026-2031) & (k tons)
- Table 99. Global Animal-derived Immune Globulin Sales Market Share by Application (2020-2025)
- Table 100. Global Animal-derived Immune Globulin Sales Market Share by Application (2026-2031)
- Table 101. Global Animal-derived Immune Globulin Revenue by Application (2020-2025) & (US$ Million)
- Table 102. Global Animal-derived Immune Globulin Revenue by Application (2026-2031) & (US$ Million)
- Table 103. Global Animal-derived Immune Globulin Revenue Market Share by Application (2020-2025)
- Table 104. Global Animal-derived Immune Globulin Revenue Market Share by Application (2026-2031)
- Table 105. Global Animal-derived Immune Globulin Price by Application (2020-2025) & (US$/ton)
- Table 106. Global Animal-derived Immune Globulin Price by Application (2026-2031) & (US$/ton)
- Table 107. Key Raw Materials
- Table 108. Raw Materials Key Suppliers
- Table 109. Animal-derived Immune Globulin Distributors List
- Table 110. Animal-derived Immune Globulin Customers List
- Table 111. Animal-derived Immune Globulin Industry Trends
- Table 112. Animal-derived Immune Globulin Industry Drivers
- Table 113. Animal-derived Immune Globulin Industry Restraints
- Table 114. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Animal-derived Immune Globulin Product Image
- Figure 5. Global Animal-derived Immune Globulin Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Animal-derived Immune Globulin Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Animal-derived Immune Globulin Sales (2020-2031) & (k tons)
- Figure 8. Global Animal-derived Immune Globulin Average Price (US$/ton) & (2020-2031)
- Figure 9. Liquid Product Image
- Figure 10. Powder Product Image
- Figure 11. Hospital Product Image
- Figure 12. Clinic Product Image
- Figure 13. Global Animal-derived Immune Globulin Revenue Share by Manufacturers in 2024
- Figure 14. Global Manufacturers of Animal-derived Immune Globulin, Manufacturing Sites & Headquarters
- Figure 15. Global Top 5 and 10 Animal-derived Immune Globulin Players Market Share by Revenue in 2024
- Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 17. Global Animal-derived Immune Globulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 18. Global Animal-derived Immune Globulin Sales by Region in 2024
- Figure 19. Global Animal-derived Immune Globulin Revenue by Region in 2024
- Figure 20. North America Animal-derived Immune Globulin Market Size by Country in 2024
- Figure 21. North America Animal-derived Immune Globulin Sales Market Share by Country (2020-2031)
- Figure 22. North America Animal-derived Immune Globulin Revenue Market Share by Country (2020-2031)
- Figure 23. United States Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 24. Canada Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 25. Europe Animal-derived Immune Globulin Market Size by Country in 2024
- Figure 26. Europe Animal-derived Immune Globulin Sales Market Share by Country (2020-2031)
- Figure 27. Europe Animal-derived Immune Globulin Revenue Market Share by Country (2020-2031)
- Figure 28. Germany Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 29. France Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 30. U.K. Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 31. Italy Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 32. Netherlands Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. Asia Pacific Animal-derived Immune Globulin Market Size by Country in 2024
- Figure 34. Asia Pacific Animal-derived Immune Globulin Sales Market Share by Country (2020-2031)
- Figure 35. Asia Pacific Animal-derived Immune Globulin Revenue Market Share by Country (2020-2031)
- Figure 36. China Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Japan Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 38. South Korea Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 39. India Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 40. Australia Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 41. China Taiwan Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 42. Southeast Asia Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 43. Southeast Asia Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 44. South America Animal-derived Immune Globulin Market Size by Country in 2024
- Figure 45. South America Animal-derived Immune Globulin Sales Market Share by Country (2020-2031)
- Figure 46. South America Animal-derived Immune Globulin Revenue Market Share by Country (2020-2031)
- Figure 47. Mexico Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. Brazil Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 49. Argentina Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 50. Middle East and Africa Animal-derived Immune Globulin Market Size by Country in 2024
- Figure 51. Middle East and Africa Animal-derived Immune Globulin Sales Market Share by Country (2020-2031)
- Figure 52. Middle East and Africa Animal-derived Immune Globulin Revenue Market Share by Country (2020-2031)
- Figure 53. Turkey Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 54. Saudi Arabia Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 55. UAE Animal-derived Immune Globulin Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 56. Global Animal-derived Immune Globulin Sales Market Share by Type (2020-2031)
- Figure 57. Global Animal-derived Immune Globulin Revenue Market Share by Type (2020-2031)
- Figure 58. Global Animal-derived Immune Globulin Price (US$/ton) by Type (2020-2031)
- Figure 59. Global Animal-derived Immune Globulin Sales Market Share by Application (2020-2031)
- Figure 60. Global Animal-derived Immune Globulin Revenue Market Share by Application (2020-2031)
- Figure 61. Global Animal-derived Immune Globulin Price (US$/ton) by Application (2020-2031)
- Figure 62. Animal-derived Immune Globulin Value Chain
- Figure 63. Animal-derived Immune Globulin Production Mode & Process
- Figure 64. Direct Comparison with Distribution Share
- Figure 65. Distributors Profiles
- Figure 66. Animal-derived Immune Globulin Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


